- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03994978
Bowel Function/QoL After Elective Sigmoidectomy vs. Conservative Management for Recurrent Uncomplicated Diverticulitis
January 2, 2023 updated by: University Hospital, Basel, Switzerland
Preoperative vs. Postoperative Bowel Function and Quality of Life in Patients Undergoing Elective Sigmoidectomy vs. Conservative Management for Recurrent Uncomplicated Diverticulitis (FRESCO-Trial)
The decision to perform a surgical intervention or not after recovery from repeated uncomplicated episodes of acute diverticulitis remains controversial and the literature shows different conflicting approaches based on low-quality evidence.The goal of this trial is to achieve a better understanding of the impact of surgery on bowel function and QoL in patients with recurrent uncomplicated sigmoid diverticulitis in order to develop treatment guidelines.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The prevalence of diverticular disease of sigmoid in the Western has increased over the past century and our know-how of this disease and its management continues to evolve.
International experts have tried to standardize the surgical approach to patients with recurrent episodes of sigmoid diverticulitis but, to date, no guidelines are universally recognized.The American Society of Colon and Rectal Surgeons (ASCRS) and the World Society of Emergency Surgery (WSES) recommend an individualized approach after recovery from uncomplicated acute diverticulitis to plan an elective sigmoid resection.
The impact of ongoing disorders on quality of life (QoL) and not the number of previous episodes of diverticulitis should be the most determining factor.
The German guideline by the Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) recommend an elective sigmoid resection after a careful risk/benefit assessment depending on the clinical presentation in the disease-free interval in patients with chronic relapsing diverticulitis.The Danish Surgical Society (DSS) is more restrained and mentions the unnecessary risk in terms of morbidity and mortality to the individual as well as costs to society in prophylactic resection of the sigmoid.
Therefore, they recommend that elective surgery should be probably limited to symptomatic cases not amenable to conservative measures.
Moreover, recent studies have demonstrated that the number of attacks of diverticulitis is not necessarily a prevailing factor in defining the suitability of surgery and the operation itself carries significant morbidity and mortality.
The German guidelines describe also a persistence of the symptoms in patients who underwent sigmoid resection in 22-25%.
An uncomplicated diverticulitis is generally considered a mild and self-limiting disease, performing a potentially harmful procedure in these patients does not seem justified.
However, elective resection may be an appropriate solution for a more selective group of patients who suffer greatly from their disease.
Many studies have consistently shown that 40-80% remain symptomatic after conservative treatment, leading to impaired health-related Quality of life (HRQoL) and increased costs.
Study Type
Observational
Enrollment (Actual)
252
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bettina Wölnerhanssen, MD
- Phone Number: 0041616858585
- Email: bettina.woelnerhanssen@claraspital.ch
Study Locations
-
-
-
Basel, Switzerland
- St. Claraspital Basel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with recurrent episodes of diverticulitis with indication of further treatment.The physician decides which therapy (conservative or surgical) will be carried out.
Description
Inclusion Criteria:
- Patients with recurrent uncomplicated diverticulitis and surgical indication for sigmoid resection
- Patients with recurrent uncomplicated diverticulitis and non-surgical indication for conservative management
- Confirmation of at least one episode of acute uncomplicated diverticulitis in computed tomography
Exclusion Criteria:
- Patients aged under 18.
- Patients unable to understand an informed consent.
- Patients with chronic pain disorder.
- Patients with sigmoid fistulas
- Emergency operations.
- Pregnant women or lactation.
- Patients with other severe gastrointestinal diseases, such as inflammatory bowel diseases (IBD), carcinoma or immunologic disorders.
- Patients unable to perform surgery or high-risk patients according to the American Society of Anesthesiology (ASA 4 grade or higher)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Surgical group
Patients with uncomplicated recurrent diverticulitis undergoing elective sigmoid resection
|
elective sigmoidectomy
|
Conservative group
Patients with uncomplicated recurrent diverticulitis with conservative treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in grade of fecal incontinence incontinence score
Time Frame: change from baseline to 12 months after intervention
|
Fecal incontinence measured by total "Vaizey-Wexner incontinence score" ranging from 0 to 24; lower values represent better outcome
|
change from baseline to 12 months after intervention
|
Change in grade of constipation
Time Frame: change from baseline to 12 months after intervention
|
Constipation measured by total "Cleveland constipation score" ranging from 0 to 30; lower values represent better outcome
|
change from baseline to 12 months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in gastrointestinal quality of Life: gastrointestinal quality of life score" (GIQLI score)
Time Frame: change from baseline to 12 months after intervention
|
Gastrointestinal quality of life measured by total "gastrointestinal quality of life score" (GIQLI score) ranging from 0-144; higher values represent better outcome
|
change from baseline to 12 months after intervention
|
Change in erectile function
Time Frame: change from baseline to 12 months after intervention
|
Erectile function measured by total "international index of erectile function" (IIEF-5-score) ranging from 5 to 25; higher values represent better outcome
|
change from baseline to 12 months after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Bettina Wölnerhanssen, MD, St. Clara Research Ltd.
- Principal Investigator: Daniel Steinemann, MD, Clarunis
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 8, 2019
Primary Completion (Actual)
December 1, 2022
Study Completion (Actual)
December 27, 2022
Study Registration Dates
First Submitted
June 19, 2019
First Submitted That Met QC Criteria
June 19, 2019
First Posted (Actual)
June 21, 2019
Study Record Updates
Last Update Posted (Actual)
January 4, 2023
Last Update Submitted That Met QC Criteria
January 2, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FRESCO Trial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diverticulitis of Sigmoid
-
Cantonal Hospital of St. GallenCompletedSigmoid Diverticulitis (Hinchey I and II) | Sigmoid Diverticulosis With Two or More Attacks of DiverticulitisSwitzerland
-
Hospital Central de la Defensa Gómez UllaCompletedDiverticulitis | Diverticulitis Colon | Diverticulitis of Sigmoid | Diverticulitis; Perforation, BowelSpain
-
Kepler University HospitalKrankenhaus Barmherzige Schwestern Linz; Elisabethinen HospitalRecruitingDiverticulitis of SigmoidGermany, Austria
-
IHU StrasbourgCompletedSigmoid Diverticulosis | Sigmoid Diverticulitis | Colorectal MalignancyFrance
-
Hospital General Universitario Reina Sofía de MurciaCompletedDiet Modification | Diverticulitis | Dietary Modification | Diverticulitis, Colonic | Acute Diverticulitis | Uncomplicated Diverticular Disease | Diverticulitis of SigmoidSpain
-
University of CagliariAzienda Ospedaliero Universitaria di CagliariRecruitingSepsis | Diverticular Diseases | Diverticulitis, Colonic | Acute Diverticulitis | Diverticulitis of Sigmoid | Acute Diverticular PerforationItaly
-
Nantes University HospitalRecruitingSigmoid Diverticulosis | Sigmoid CancerFrance
-
Cantonal Hosptal, BasellandUnknownColon Adenoma | Sigmoid Diverticulosis | Sigmoid Diverticulitis | Rectal ProlapseSwitzerland
-
Helsinki University Central HospitalActive, not recruitingDiverticulum | Colon, SigmoidFinland
-
University Hospital, CaenCompletedColorectal Surgery | Sigmoid DiverticulosisFrance
Clinical Trials on elective sigmoidectomy
-
Nantes University HospitalRecruitingSigmoid Diverticulosis | Sigmoid CancerFrance
-
Cantonal Hosptal, BasellandUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentUnknownPerforated DiverticulitisNetherlands, Belgium
-
Jean DubuissonNot yet recruitingQuality of Life | Adnexal Diseases | Sexual Dysfunction | Pelvic Pain | Complication | Sexuality | Dyspareunia | Gynecologic Disease | Adnexal Mass | Pathology | Adnexal Cyst
-
Aarhus University HospitalCompletedRespiratory Disorders | Intensive Care, NeonatalDenmark
-
University of AarhusRanders Regional HospitalRecruitingQuality of Life | Diverticulitis Colon | Diverticular Disease of Left Side of ColonDenmark
-
Universitair Ziekenhuis BrusselRecruitingAnalyse Neuromuscular Monitoring for Developing a Model to Predict TOF Ratio During AnesthesiaBelgium
-
Sara TimergaCompletedPostoperative Nausea and VomitingEthiopia
-
Zealand University HospitalCompletedMyocardial InjuryDenmark
-
National Cancer Center, KoreaCompletedColorectal CancerKorea, Republic of